他喷他多对小鼠脾脏细胞因子产生的影响
该研究在小鼠中比较了他喷他多、瑞波西汀与吗啡对脾脏细胞因子的影响。急性他喷他多未改变细胞因子,而吗啡抑制所有细胞因子;慢性给药7天后他喷他多和瑞波西汀不影响细胞因子,且在神经病理性疼痛小鼠中他喷他多和瑞波西汀组IL-10和IL-4显著高于吗啡组。
要点
- 急性他喷他多不改变小鼠脾脏细胞因子产生。
- 吗啡急性给药广泛抑制IFN-γ、IL-2、IL-10和IL-4。
- 慢性他喷他多对脾脏细胞因子无显著影响,与吗啡不同。
核心结论
- 急性和慢性他喷他多似乎对小鼠脾脏细胞因子具有保护作用,与吗啡的广泛抑制形成对比。
研究设计与样本
- 研究将他喷他多、瑞波西汀和吗啡皮下注射到 naïve 小鼠和坐骨神经慢性压迫损伤小鼠,急性或慢性治疗7天后用酶联免疫吸附试验测定脾脏细胞因子。
主要发现
- 急性他喷他多与生理盐水组相比未改变细胞因子产生,而吗啡10 mg/kg抑制所有细胞因子:IFN-γ MD 12,400(95%CI 7760–17,040,P<.001),IL-2 MD 216.2(95%CI 47.69–384.7,P<.01),IL-10 MD 868(95%CI 523.7–1212,P<.001),IL-4 MD 17.26(95%CI 10.32–24.20,P<.001)。
- 吗啡10 mg/kg与他喷他多20 mg/kg之间差异显著:IFN-γ MD -11,600(95%CI -16,240至-6960,P<.001),IL-2 MD -334.2(95%CI -502.7至-165.7,P<.001),IL-10 MD -959(95%CI -1303至-614.7,P<.001),IL-4 MD -18.66(95%CI -25.60至-11.72,P<.001)。
- 慢性注射7天后,他喷他多和瑞波西汀与生理盐水组相比未显著影响细胞因子。
- 在神经病理性疼痛小鼠中,慢性压迫损伤小鼠所有细胞因子较假手术组显著降低,但治疗7天后他喷他多和瑞波西汀组IL-10和IL-4显著高于吗啡组:IL-10 MD -926.4(95%CI -1664至-188.5,P<.01),IL-4 MD -8.15(95%CI -12.46至-3.84,P<.001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Opioid drugs affect immunity, but not all opioid drugs share the same immunomodulatory properties. Tapentadol is an analgesic drug with a dual synergistic mechanism of action: µ-opioid receptor agonism and noradrenaline reuptake inhibition. Weaker µ-opioid receptor agonism combined with noradrenaline reuptake inhibition results in potent analgesia with reduced opioid side effects. We evaluated the impact of tapentadol on splenic cytokine in normal and in hyperalgesia/allodynia mice, comparing it with morphine and reboxetine, a noradrenaline reuptake inhibitor. METHODS: Tapentadol, reboxetine, and morphine were injected subcutaneously into naïve and mice that underwent sciatic nerve chronic constriction injury, and their effect on splenic cytokines (interferon-γ [IFN-γ], interleukin [IL]-2, IL-10, and IL-4) was measured by enzyme-linked immunosorbent assay after acute or chronic treatment. Nociceptive thresholds, thermal hyperalgesia, and allodynia also were assessed. Data were analyzed with 2-way analysis of variance (behavior) or 1-way analysis of variance (cytokines) followed by Bonferroni post hoc test. RESULTS: Primary outcomes of our study were the effects of drugs on splenic cytokines. Our data indicate that acute tapentadol did not modify cytokine production in comparison with animals that received saline, whereas morphine suppressed all the cytokines: saline versus morphine 10 mg/kg (mean difference [MD], 95% confidence interval [CI]: IFN-γ = 12,400 [7760, 17,040], P < .001; IL-2 = 216.2 [47.69, 384.7], P < .01; IL-10 = 868 [523.7, 1212], P < .001; and IL-4 = 17.26 [10.32, 24.20], P < .001). A significant difference also was present between morphine and tapentadol (morphine 10 mg/kg versus tapentadol 20 mg/kg: MD [95% CI]: IFN-γ = -11,600 [-16,240, -6960], P < .001; IL-2 = -334.2 [-502.7, -165.7], P < .001; IL-10 = -959 [-1303, -614.7], P < .001; IL-4 = -18.66 [-25.60, -11.72], P < .001). When chronically injected for 7 days, tapentadol and reboxetine did not significantly affect cytokines when compared with saline-treated animals. The immunoprofile of tapentadol was different from that of morphine also in mice that were in a condition of neuropathic pain. All cytokines appeared significantly decreased in mice that received a chronic constriction injury in comparison with sham animals but, after 7 days of treatment, with a similar antihyperalgesic profile, IL-10 and IL-4 were significantly increased in tapentadol and reboxetine animals in comparison with morphine mice (morphine versus tapentadol: MD [95% CI], IL-10 = -926.4 [-1664, -188.5], P < .01; IL-4 = -8.15 [-12.46, -3.84], P < .001). CONCLUSIONS: Acute and chronic tapentadol seem to be protective of splenic cytokines in contrast with morphine, which exerts a generalized suppression on all cytokines.
引用
- Franchi S, Amodeo G, Gandolla M, et al. Effect of Tapentadol on Splenic Cytokine Production in Mice. Anesth Analg. 2017. PMID: 27997452. doi:10.1213/ANE.0000000000001669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。